Patents by Inventor Kevin T. Nguyen

Kevin T. Nguyen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEALING MEMBER FOR PROSTHETIC HEART VALVE
    Publication number: 20240115375
    Abstract: A prosthetic heart valve includes an annular frame that is radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration. The frame has a plurality of circumferentially extending rows of angled struts, each row of angled struts comprising angled struts arranged in a zig-zag pattern. The prosthetic heart valve further includes a leaflet structure positioned within the frame and secured thereto, and an outer sealing member mounted outside of the frame. The sealing member has an undulating outflow edge portion forming a plurality of triangular projections that are connected to and shaped to correspond to the zig-zag pattern of one of the rows of angled struts. The outer sealing member is sized to fit snugly against the outer surface of the frame when the frame is in the expanded configuration.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 11, 2024
    Inventors: Lien Huong Thi Hoang, Son V. Nguyen, Hien Tran Ngo, Vivian Tran, Russell T. Joseph, Dinesh L. Sirimanne, Kevin D. Rupp, Diana Nguyen-Thien-Nhon
  • System and method for determining recipient information from a document
    Patent number: 10834286
    Abstract: A system and method for determining where to send a document from information printed on the document includes a scanner configured to scan a document, and a processor configured to use optical character recognition on the scanned document to determine recipient contact information. The processor generates a user-selectable list of one or more of the determined recipients and receives a user selection of one or more recipients to receive the document. The processor then transmits the document to the selected recipients using a modality suitable to the recipient's contact information, which includes faxing the document to the recipient when the recipient's contact information is a fax number, emailing the document to the recipient when the recipient's contact information is an email address, and transmitting the document when the recipient is a network file server.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: November 10, 2020
    Assignee: Toshiba TEC Kabushiki Kaisha
    Inventors: Brendon Wai, Kevin T. Nguyen, Sai Geetha Kandepalli Cherukuru
  • N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
    Patent number: 7217716
    Abstract: Compounds represented by Formula (I): (I) or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain
    Type: Grant
    Filed: February 20, 2002
    Date of Patent: May 15, 2007
    Assignee: Merck & Co., Inc.
    Inventors: Christopher F. Claiborne, David A. Claremon, Brian E. Libby, John W. Butcher, John A. McCauley, Nigel J. Liverton, Peter M. Munson, Kevin T. Nguyen, Brian Phillips, Wayne Thompson
  • N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
    Patent number: 7053089
    Abstract: Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.
    Type: Grant
    Filed: February 20, 2002
    Date of Patent: May 30, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Christopher F. Claiborne, John W. Butcher, David A. Claremon, Brian E. Libby, Nigel J. Liverton, Peter M. Munson, Kevin T. Nguyen, Brian Phillips, Wayne Thompson, John A. McCauley
  • N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
    Publication number: 20040209889
    Abstract: Compounds represented by Formula (I): (I)or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.
    Type: Application
    Filed: July 29, 2003
    Publication date: October 21, 2004
    Inventors: Christopher F Claiborne, David A Claremon, Brian E Libby, John W Butcher, John A McCauley, Nigel J Liverton, Peter M Munson, Kevin T Nguyen, Brian Phillips, Wayne Thompson
  • N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
    Publication number: 20020165241
    Abstract: Compounds represented by Formula (I): 1
    Type: Application
    Filed: February 20, 2002
    Publication date: November 7, 2002
    Inventors: Christopher F. Claiborne, John W. Butcher, David A. Claremon, Brian E. Libby, Nigel J. Liverton, Peter M. Munson, Kevin T. Nguyen, Brian Phillips, Wayne Thompson, John A. McCauley
  • Compounds having cytokine inhibitory activity
    Patent number: 6291457
    Abstract: There are disclosed compounds of formula (I) and pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis.
    Type: Grant
    Filed: June 19, 2000
    Date of Patent: September 18, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Christopher F. Claiborne, David A. Claremon, Nigel J. Liverton, Kevin T. Nguyen